Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
NVInVivo Therapeutics Holdings Corporation logo

InVivo Therapeutics Holdings Corporation (NVIV)

NASDAQ Capital Market · Currency in USD
$0.32 ▼ -0.17 (-34.28%)
At close: Feb 12, 4:00 PM ET. Market closed.
$0.23 ▼ -0.09 (-27.97%)
After hours: Feb 12, 7:56 PM ET

Summary

Previous Close
$0.49
Open
$0.41
Day's Range
$0.30 – $0.41
52 Week Range
$0.22 – $2.40
Volume
1,609,868
Avg. Volume
3,887,771
Market Cap
$995.92K
Beta (5Y Monthly)
0.66
PE Ratio (TTM)
--
EPS (TTM)
-$6.62
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: InVivo Therapeutics Holdings Corporation

Sector
Healthcare
Industry
Biotechnology
Full-time employees
6
CEO
Richard M. Toselli

InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold.

Earnings

DateEst.Actual
Nov 8, 2023–-$0.87
Aug 9, 2023–-$1.97
Jun 27, 2023–-$1.94
Mar 13, 2023–-$2.25
Nov 7, 2022–-$1.98
Aug 8, 2022–-$1.97

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on NVIV and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.